• Home
  • News
  • Analysis
  •  
    Regions
    • South Asia
    • North America
    • Europe
    • Central Asia
    • Australasia
    • MENA
    • Southeast Asia
    • Greater China
    • North Asia
  •  
    Funds
    • LPs
    • Buyout
    • Growth
    • Venture
    • Renminbi
    • Secondary
    • Credit/Special Situations
    • Infrastructure
    • Real Estate
  •  
    Investments
    • Buyout
    • Growth
    • Credit
    • Early stage
    • PIPE
  •  
    Exits
    • Buyback
    • IPO
    • Open market
    • Trade sale
  •  
    Sectors
    • Real Estate
    • Consumer
    • Financials
    • Healthcare
    • Industrials
    • Infrastructure
    • Media
    • Technology
  • Events
  • Chinese edition
  • Data & Research
  • Weekly Digest
  • Newsletters
  • Sign in
  • Events
  • Sign in
    • You are currently accessing unquote.com via your Enterprise account.

      If you already have an account please use the link below to sign in.

      If you have any problems with your access or would like to request an individual access account please contact our customer service team.

      Phone: +44 (0)870 240 8859

      Email: customerservices@incisivemedia.com

      • Sign in
     
      • Saved articles
      • Newsletters
      • Account details
      • Contact support
      • Sign out
     
  • Follow us
    • RSS
    • Twitter
    • LinkedIn
    • Newsletters
  • Free Trial
  • Subscribe
  • Weekly Digest
  • Chinese edition
  • Data & Research
    • Latest Data & Research
      2023-china-216x305
      Regional Reports

      The reports review the year's local private equity and venture capital activity and are filled with up-to-date data and intelligence on fundraising, investments, exits and M&A. The regional reports also feature information on key companies.

      Read more
      2016-pevc-cover
      Industry Review

      Asian Private Equity and Venture Capital Review provides an independent overview of the private equity, venture capital and M&A activities in the Asia region. It delivers insights on investments made, capital raised, sector specific figures and more.

      Read more
      AVCJ Database

      AVCJ Database is the ultimate link between Asian dealmakers and those who provide advisory, financial, legal and technological services to the private equity, venture capital and M&A industries. It is packed with facts and figures on more than 153,000 companies and almost 117,000 transactions.

      Read more
AVCJ
AVCJ
  • Home
  • News
  • Analysis
  • Regions
  • Funds
  • Investments
  • Exits
  • Sectors
  • You are currently accessing unquote.com via your Enterprise account.

    If you already have an account please use the link below to sign in.

    If you have any problems with your access or would like to request an individual access account please contact our customer service team.

    Phone: +44 (0)870 240 8859

    Email: customerservices@incisivemedia.com

    • Sign in
 
    • Saved articles
    • Newsletters
    • Account details
    • Contact support
    • Sign out
 
AVCJ
  • Southeast Asia

Temasek-backed healthcare firm HCG acquires majority stake in BACC

  • Andrew Woodman
  • 31 May 2013
  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Save this article  
  • Send to  

HealthCare Global Enterprises (HCG), an Indian cancer treatment specialist backed by Temasek Holdings, has acquired a majority stake in Bangalore Assisted Conception Centre (BACC), a leading provider of fertility care. Details of the transaction were not disclosed.

HCG provides cancer care treatment, imaging and laboratory services, clinical trials and research services. It has 23 oncology centers in India and two overseas. Temasek invested INR1.3 billion ($24 million) in March, facilitating the exit of Evolvence India Life Sciences Fund, a vehicle managed by 3 Logi Capital.

BACC, which was started in 1990 and operates four fertility centers, has been recently rebranded as Milann - The Fertility Center. The company claims to have had over 15,000 patients successfully conceive. It also runs CREST, the only training centre for embryologists and fertility specialists in India.

"We are delighted to partner with one of the country's most accomplished fertility specialists, who has contributed immensely in the field of infertility treatment ," said Dr. B.S. Ajaikumar, chairman and CEO of HCG, in a statement. "We will build upon this expertise to help establish the nation's leading fertility care provider."

HCG is one of several examples of Indian healthcare firms that have attracted private equity investment in recent times as GPs look for ways to tap the country's growing middle class. Singular specialty healthcare companies have been of particular interest by virtue of their low capital expenditure and ease of scalability, often through acquisition.

Earlier this month India Value Fund-backed Manipal Health Enterprises invested INR400 million ($7.27 million) in another infertility specialist, Ankur Healthcare. The company was subsequently renamed as Manipal Ankur Andrology and Reproductive Services (MAARS).

Last year, India Value Fund said it would commit about INR10 billion ($179 million) to Manipal Hospitals over a three-year period, enabling the healthcare provider to more than double its hospital bed capacity - part of which would come through acquisitions.

  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Save this article  
  • Send to  
  • Topics
  • Southeast Asia
  • South Asia
  • Healthcare
  • Buyout
  • Buyouts
  • Temasek Holdings
  • India
  • Singapore
  • healthcare
  • buyout

More on Southeast Asia

Singapore fintech start-up LXA gets $10m seed round
Singapore fintech start-up LXA gets $10m seed round
  • Southeast Asia
  • 10 November 2023
Reed Smith hires Sidley Austin's Asia fund formation leader
Reed Smith hires Sidley Austin's Asia fund formation leader
  • Southeast Asia
  • 02 November 2023
Polaris leads $27m round for Singapore's Engine Biosciences
Polaris leads $27m round for Singapore's Engine Biosciences
  • Southeast Asia
  • 01 November 2023
Deal focus: Algae-based bio-plastics come to Asia
Deal focus: Algae-based bio-plastics come to Asia
  • Southeast Asia
  • 01 November 2023

Latest News

Asian GPs slow implementation of ESG policies - survey
Asian GPs slow implementation of ESG policies - survey

Asia-based private equity firms are assigning more dedicated resources to environment, social, and governance (ESG) programmes, but policy changes have slowed in the past 12 months, in part due to concerns raised internally and by LPs, according to a...

  • GPs
  • 10 November 2023
Singapore fintech start-up LXA gets $10m seed round
Singapore fintech start-up LXA gets $10m seed round

New Enterprise Associates (NEA) has led a USD 10m seed round for Singapore’s LXA, a financial technology start-up launched by a former Asia senior executive at The Blackstone Group.

  • Southeast Asia
  • 10 November 2023
India's InCred announces $60m round, claims unicorn status
India's InCred announces $60m round, claims unicorn status

Indian non-bank lender InCred Financial Services said it has received INR 5bn (USD 60m) at a valuation of at least USD 1bn from unnamed investors including “a global private equity fund.”

  • South Asia
  • 10 November 2023
Insight leads $50m round for Australia's Roller
Insight leads $50m round for Australia's Roller

Insight Partners has led a USD 50m round for Australia’s Roller, a venue management software provider specializing in family fun parks.

  • Australasia
  • 10 November 2023
Back to Top
  • About AVCJ
  • Advertise
  • Contacts
  • About ION Analytics
  • Terms of use
  • Privacy policy
  • Group disclaimer
  • RSS
  • Twitter
  • LinkedIn
  • Newsletters

© Merger Market

© Mergermarket Limited, 10 Queen Street Place, London EC4R 1BE - Company registration number 03879547

Digital publisher of the year 2010 & 2013

Digital publisher of the year 2010 & 2013